Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs FORM by GBY

Two GLP-1 desks, one scoreboard. We put CoreAge Rx and FORM by GBY head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 199 · Grade C

FORM by GBY

Visit FORM by GBY Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

That doesn't make FORM by GBY a bad call — it's best for readers who want the widest single-account menu and are willing to complete intake to learn what the branded and adjacent-care lines actually cost. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 on the board — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
55
Supply Reliability
95
78
Transparency
90
42
Access Breadth
93
82
Clinical Oversight
92
60
Track Record
88
68
CoreAge RxBrief Score 94 · 67FORM by GBY

Price, coverage & the tracker

CoreAge RxFORM by GBY
Brief Score94/100 (A)67/100 (C)
Semaglutide$149/mo$299/mo (compounded, no dose tiers published)
Tirzepatide$349/moNot disclosed (Zepbound membership offered, drug cost not published)
CoverageAll 50 states48 states + DC (excludes Alaska, Mississippi)
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.

FORM by GBY: First reading — one real price (compounded sema $299); everything else, including the advertised Wegovy "$95," is a membership fee or undisclosed.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.